EXHIBIT 10.20
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
FOR THE PORTIONS MARKED [***]
CONFIDENTIAL
AGREEMENT BY AND BETWEEN
IMPERIAL CHEMICAL INDUSTRIES PLC
AND
ARENA PHARMACEUTICALS, INC.
TABLE OF CONTENTS
--PLEASE NOTE--
Provisions Within This Agreement Are Deemed "CONFIDENTIAL" In Accordance With The Terms of Article
VIII.
Reviewers are advised to confirm with their attorney as to any obligations and/or requirements regarding review
of this Agreement.
CONFIDENTIAL
AGREEMENT
This Agreement ("Agreement") is effective as of June 15, 2001 ("Effective Date") by and between IMPERIAL
CHEMICAL INDUSTRIES PLC, having a place of business at London SWIP 3JF, United Kingdom ("ICI")
and ARENA PHARMACEUTICALS, INC., having a place of business at 6166 Nancy Ridge Drive, San
Diego, California, 92121 USA ("Arena").
WHEREAS, ICI is a company which produces specialty products including fragrances, flavors and food
ingredients;
WHEREAS, Arena is a biopharmaceutical organization focused on the development and use of its proprietary
technology for discovery of modulators of G protein-coupled receptors;
WHEREAS, ICI desires to collaborate with Arena to identify broad-spectrum modulators of specific G protein-
coupled receptors to enhance the discovery processes in the fragrances, flavors and food industry;
PAGE
Article I. Definitions 1
Article II. Feasibility Study 4
Article III. Exclusivity 5
Article IV. Payments to Arena 6
Article V. Utilization of Data 7
Article VI. Technology License 7
Article VII. Royalty Payments 8
Article VIII. Confidentiality